| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Irbesartan and Hydrochlorothiazide Tablets USP safely and effectively. See full prescribing information for Irbesartan and Hydrochlorothiazide Tablets USP. Irbesartan and Hydrochlorothiazide Tablets, USP Initial U.S. Approval: 1997 | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Cefdinir Capsules, USP Rx Only | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use ATACAND safely and effectively. See full prescribing information for ATACAND. ATACAND ® (candesartan cilexetil) TABLETS INITIAL U.S. APPROVAL: 1998 | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use pioglitazone tablets safely and effectively. See full prescribing information for pioglitazone tablets. Pioglitazone Tablets USP for oral use Initial U.S. Approval: 1999 | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Drug Facts | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Drug Facts | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Pioglitazone Tablets safely and effectively. See full prescribing information for Pioglitazone Tablets. Pioglitazone Tablets for oral use Initial U.S. Approval: 1999 | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Pioglitazone Tablets safely and effectively. See full prescribing information for Pioglitazone Tablets. Pioglitazone Tablets for oral use Initial U.S. Approval: 1999 | 2 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Pioglitazone Tablets safely and effectively. See full prescribing information for Pioglitazone Tablets. Pioglitazone Tablets for oral use Initial U.S. Approval: 1999 | 2 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Pioglitazone Tablets safely and effectively. See full prescribing information for Pioglitazone Tablets. Pioglitazone Tablets for oral use Initial U.S. Approval: 1999 | 1 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use ACTOS safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone hydrochloride) tablets for oral use Initial U.S. Approval: 1999 | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULES 3160 Rx only | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND HCT® 16-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32-12.5 ( candesartan cilexetil−hydrochlorothiazide ) TABLETS ATACAND HCT® 32–25 candesartan cilexetil-hydrochlorothiazide | 2 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Savella safely and effectively. See full prescribing information for Savella. Savella® (milnacipran HCl) Tablets Initial U.S. Approval: 2009 | 5 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use ACTOS safely and effectively. See full prescribing information for ACTOS. ACTOS (pioglitazone hydrochloride) tablets for oral use Initial U.S. Approval: 1999 | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Cefdinir Capsules | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Cefdinir Capsules | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Cefdinir Capsules | 3 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Savella safely and effectively. See full prescribing information for Savella. Savella® (milnacipran HCl) Tablets Initial U.S. Approval: 2009 | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Cilostazol Tablets, USP 50 mg and 100 mg Rx only | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | These highlights do not include all the information needed to use Savella safely and effectively. See full prescribing information for Savella. Savella® (milnacipran HCl) Tablets Initial U.S. Approval: 2009 | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | Cilostazol Tablets 50 mg and 100 mg Rx only | 1 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | ACTOS (PIOGLITAZONE HYDROCHLORIDE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3584 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | SAVELLA (MILNACIPRAN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3257 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND (CANDESARTAN CILEXETIL) TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND (CANDESARTAN CILEXETIL) TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CILOSTAZOL TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | IRBESARTAN (IRBESARTAN ) TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND (CANDESARTAN CILEXETIL) TABLET [ASTRAZENECA LP] | 18 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND HCT (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET ATACAND HCT (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [ASTRAZENECA LP] | 18 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CILOSTAZOL TABLET [EON LABS, INC.] | 18 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | SAVELLA (MILNACIPRAN HYDROCHLORIDE) TABLET, FILM COATED SAVELLA (MILNACIPRAN HYDROCHLORIDE) KIT [FOREST LABORATORIES, INC.] | 15 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFPODOXIME PROXETIL TABLET, FILM COATED [SANDOZ INC] | 14 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | ACTOS (PIOGLITAZONE) TABLET [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 12 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFPODOXIME PROXETIL TABLET, FILM COATED [PUTNEY INC] | 12 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [ACTAVIS PHARMA, INC.] | 12 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [SANDOZ INC] | 11 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [DAVA PHARMACEUTICALS INC] | 10 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [AUROBINDO PHARMA LIMITED] | 9 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CILOSTAZOL TABLET [COREPHARMA LLC.] | 9 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLET [MYLAN PHARMACEUTICALS INC.] | 8 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | PLETAL (CILOSTAZOL) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 8 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| Carboxymethylcellulose Calcium | INACTIVE INGREDIENT | UTY7PDF93L | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | SANKAIJO (DOCUSATE SODIUM, SENNOSIDES) TABLET [SATO PHARMACEUTICAL CO., LTD.] | 6 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL-HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE) TABLET CANDESARTAN CILEXETIL-HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE) TABLET [PAR PHARMACEUTICAL INC.] | 5 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFPODOXIME PROXETIL TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | 5 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | CILOSTAZOL TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 5 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | IRBESARTAN (IRBESARTAN ) TABLET IRBESARTAN TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 5 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED] | 5 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ACTOS (PIOGLITAZONE HYDROCHLORIDE) TABLET [CARDINAL HEALTH] | 4 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL TABLET [PAR PHARMACEUTICAL INC.] | 4 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | 4 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [AUROBINDO PHARMA LIMITED] | 4 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [RANBAXY PHARMACEUTICALS INC] | 4 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [SANDOZ INC] | 4 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLET [APOTEX CORP.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL TABLET CANDESARTAN CILEXETIL TABLET [APOTEX CORP] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFPODOXIME PROXETIL TABLET, FILM COATED [GEN-SOURCE RX] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFPODOXIME PROXETIL TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | IRBESARTAN TABLET [CAMBER PHARMACEUTICALS, INC.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [ACCORD HEALTHCARE, INC.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [INTERNATIONAL LABS, INC.] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONEHYDROCHLORIDE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 3 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND (CANDESARTAN CILEXETIL) TABLET [CARDINAL HEALTH] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND (CANDESARTAN CILEXETIL) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ATACAND (CANDESARTAN CILEXETIL) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL TABLET [SANDOZ INC] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [BLUEPOINT LABORATORIES] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [ORCHIDPHARMA INC] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [REDPHARM DRUG INC.] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFPODOXIME PROXETIL TABLET, FILM COATED [NORTHSTAR RX LLC] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CILOSTAZOL TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [AMERICAN HEALTH PACKAGING] | 2 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [MACLEODS PHARMACEUTICALS LIMITED] | 2 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | SAVELLA (MILNACIPRAN HYDROCHLORIDE) TABLET, FILM COATED [CARDINAL HEALTH] | 2 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | SAVELLA (MILNACIPRAN HYDROCHLORIDE) TABLET, FILM COATED [UNIT DOSE SERVICES] | 2 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | ACTOS (PIOGLITAZONE) TABLET [REMEDYREPACK INC. ] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CANDESARTAN CILEXETIL TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR (CEFDINIR) CAPSULE [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR (CEFDINIR) CAPSULE [LUPIN PHARMACEUTICALS INC] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [CITRON PHARMA LLC] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [NORTHSTAR RX LLC] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | CEFDINIR CAPSULE [PREFERRED PHARMACEUTICALS INC.] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | IRBESARTAN TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | IRBESARTAN TABLET [AVPAK] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | OLANZAPINE TABLET, ORALLY DISINTEGRATING [CARDINAL HEALTH] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [GEN-SOURCE RX] | 1 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE HYDROCHLORIDE TABLET [GOLDEN STATE MEDICAL SUPPLY] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [CLINICAL SOLUTIONS WHOLESALE] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [INTERNATIONAL LABS, INC.] | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [TEVA PHARMACEUTICALS USA INC] | 1 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | UTY7PDF93L | SAVELLA (MILNACIPRAN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 1 | |